Request Demo
Last update 10 Jul 2025
CAN-1012
Last update 10 Jul 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms CAN 1012, CAN-1012, CAN007 |
Target |
Action agonists |
Mechanism TLR7 agonists(Toll like receptor 7 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with CAN-1012NCT06410703
A Phase Ib/IIa, Dose Escalation, Open-Label Study of Intratumoral CAN1012 Combined With PD-1 in Patients With Unresectable or Metastatic Advanced Solid Tumors
CTR20241555
瘤内注射CAN1012注射液联合特瑞普利单抗在晚期实体瘤患者中的安全性、耐受性及初步有效性的Ib/IIa 期临床试验
[Translation] Phase Ib/IIa clinical trial to evaluate the safety, tolerability and preliminary efficacy of intratumoral CAN1012 injection combined with toripalimab in patients with advanced solid tumors
NCT05580991
A Phase 1, Dose Escalation, Open-Label Study of Intratumoral CAN1012 in Subjects with Unresectable or Metastatic Advanced Solid Tumors
100 Clinical Results associated with CAN-1012
Login to view more data
100 Translational Medicine associated with CAN-1012
Login to view more data
100 Patents (Medical) associated with CAN-1012
Login to view more data
100 Deals associated with CAN-1012
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Locally Advanced Malignant Solid Neoplasm | Phase 2 | China | 27 Jun 2024 | |
| Breast Cancer | Phase 2 | China | - | |
| Liposarcoma | Phase 2 | China | - | |
| Melanoma | Phase 2 | China | - | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 09 Sep 2022 | |
| Colorectal Cancer | Phase 1 | China | 09 Sep 2022 | |
| Colorectal Cancer | Phase 1 | China | 09 Sep 2022 | |
| Merkel Cell Carcinoma | Phase 1 | China | 09 Sep 2022 | |
| Merkel Cell Carcinoma | Phase 1 | China | 09 Sep 2022 | |
| Penile Neoplasms | Phase 1 | China | 09 Sep 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free